Patents by Inventor Philip Tuke

Philip Tuke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
    Publication number: 20070031452
    Abstract: The invention provides viral material and nucleotide fragments associated with multiple sclerosis and/or rheumatoid arthritis for use in method of diagnosis, prophylaxis, and therapy.
    Type: Application
    Filed: October 16, 2006
    Publication date: February 8, 2007
    Applicant: BIOMERIEUX
    Inventors: Herve Perron, Frederic Beseme, Frederic Bedin, Glaucia Paranhos-Baccala, Florence Komurian-Pradel, Colette Jolivet-Reynaud, Bernard Mandrand, Jeremy Garson, Philip Tuke
  • Multiple sclerosis virus
    Patent number: 6136528
    Abstract: The present invention provides a polynucleotide in substantially isolated form comprising a sequence of nucleotides which is capable of selectively hybridizing to the genome of the human multiple sclerosis virus (HMSV) or the complement thereof, wherein HMSV is characterized by:(i) a positive stranded RNA genome;(ii) said genome comprising one or more open reading frames (ORF) encoding protein(s) or polyprotein(s);(iii) said genome encoding a reverse transcriptase enzyme; and(v) said genome comprising nucleotide sequences which are homologous to or selectively hybridizable with any one of the nucleotide sequences illustrated in SEQ ID NOS:1 to 6.
    Type: Grant
    Filed: November 22, 1995
    Date of Patent: October 24, 2000
    Assignees: University College London, Biomerieux S.A.
    Inventors: Jeremy Garson, Philip Tuke